pharma

Leveraged & Inverse Content Hub

As M&A Deals Rise, Can Biotech Pharma Break Loose?

As M&A Deals Rise, Can Biotech Pharma Break Loose?

By Ben HernandezSeptember 19, 2025

Investing

'PILL' ETF Gains on $21.4B GE Biopharma Business Sale

‘PILL’ ETF Gains on $21.4B GE Biopharma Business Sale

By Ben HernandezFebruary 25, 2019

Leveraged & Inverse Content Hub

Biopharma R&D Trends Could Bode Well for This ETF

Big Biopharma Mergers Could Fuel These ETFs in 2019

By Ben HernandezJanuary 10, 2019

Equity ETFs

A 'PILL' ETF to Cure Ailing Portfolios

A ‘PILL’ ETF to Cure Ailing Portfolios

By Ben HernandezJuly 27, 2018

Equity ETFs

Pharma, Biotech Bull ETFs Leading the Charge

Pharma, Biotech Bull ETFs Leading the Charge

By Ben HernandezJuly 12, 2018